{reportSlug=global-irritable-bowel-syndrome-treatment-market, reportId=56610, mktKeyword=Irritable Bowel Syndrome Treatment, cagr=0.00, publishDate=Jan 2024, priceOption2=6500, reportTitle=Irritable Bowel Syndrome Treatment Comprehensive Study by Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Ramosetron Hydrochloride, Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Medical Condition (IBS-constipation, IBS-diarrhea) Players and Region - Global Market Outlook to 2027, baseYr=2021, totalTableFig=200, priceOption1=3450, forecastYr=2027, noOfPages=215, reportKey=56304, breadcrum=Global Irritable Bowel Syndrome Treatment}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Jan 2024 215 Pages 68 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales
AMA Research - Asia Pacific Client Engagement Partner

Filza Sayed

APAC Client Engagement Partner